Boundless Bio, Inc. Common Stock
Symbol: BOLD (NASDAQ)
1.14
▲ (0.88%) 0.010
Company Description:
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Key Stats
- Today's Open: $1.17
- Today's High: $1.148
- Today's Low: $1.13
- Today's Volume: 25.58K
- Yesterday Close: $1.13
- Yesterday High: $1.15
- Yesterday Low: $1.13
- Yesterday Volume: 9.81K
- Last Min Volume: 8
- Last Min High: $1.14
- Last Min Low: $1.14
- Last Min VWAP: $1.14
Company Profile
- Name: Boundless Bio, Inc. Common Stock
- Website: https://www.boundlessbio.com
- Listed Date: 2024-03-28
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001782303
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $25.30M
- Round Lot: 100
- Outstanding Shares: 22.39M
- Asset Type: CS
RECENT FILINGS FOR BOLD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 8-K | View |
| 2025-05-23 | 8-K | View |
| 2025-05-09 | 10-Q | View |
| 2025-05-09 | 8-K | View |
| 2025-04-29 | ARS | View |
| 2025-04-29 | DEFA14A | View |
| 2025-04-29 | DEF 14A | View |
| 2025-04-10 | EFFECT | View |
| 2025-04-08 | CORRESP | View |
| 2025-04-08 | UPLOAD | View |
| 2025-04-01 | 8-K | View |
Latest News on BOLD